Error: Could not add to watchlist. X

Simcere Pharmaceutical Group

+ Watchlist
SCR:US
Acquired
SCR:US was acquired by null
USD
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CNY) (TTM)
3.32
Market Cap (USD)
-
Shares Outstanding (m)
51.282
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Generic Pharma
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.
ADDRESS
699-18 Xuan Wu Avenue
Nanjing, 210 042
China
PHONE
86-25-8556-6666
  • Hongquan Liu
    Chief Executive Officer
  • Jingwu Zang
    Chief Scientific Officer
  • Jindong Zhou
    Executive Vice President
  • Xiaojin Yin
    Senior VP:Research & Dev
  • Haibo Qian
    Vice President/Secretary
Show More